Avalyn Pharma is hoping to rake in…
Avalyn Pharma is hoping to rake in around $181.8 million [...]
Two months after bringing in…
Two months after bringing in Michael Cola to man the [...]
Despite the recent “feeding…
Despite the recent “feeding frenzy,” Pitchbook’s Ben Zercher told Fierce [...]
Pfizer has abandoned work on a…
Pfizer has abandoned work on a PD-L1-targeting drug that was [...]
While Big Pharmas embarked on a…
While Big Pharmas embarked on a frenzy of acquisitions over [...]
As Sanofi counts down the days…
As Sanofi counts down the days before its new leader [...]
Just a few months after ripping up…
Just a few months after ripping up the central nervous [...]
Kurma Partners has closed its…
Kurma Partners has closed its fourth biotech venture capital fund [...]
A little over a year after…
A little over a year after reabsorbing its anticoagulant abelacimab, [...]
Kyverna Therapeutics has unveiled…
Kyverna Therapeutics has unveiled the full results from its registrational [...]